We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-13.87%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$36.1B
AUM Growth
-$8.74B
(-19%)
Cap. Flow
-$2.16B
Cap. Flow
% of AUM
-6%
Top 10 Holdings %
Top 10 Hldgs %
15.58%
Holding
799
New
91
Increased
212
Reduced
361
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$347M |
| 2 |
Wayfair
W
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$140M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$131M |
| 5 |
CVS Health
CVS
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$946M |
| 2 |
SHPG
Shire pic
SHPG
|
+$472M |
| 3 |
Deere & Co
DE
|
+$326M |
| 4 |
COL
Rockwell Collins
COL
|
+$286M |
| 5 |
ANDV
Andeavor
ANDV
|
+$221M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.2% |
| 2 | Technology | 13.74% |
| 3 | Financials | 12.51% |
| 4 | Industrials | 12.28% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSTX
501
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $10.4M | 0.03% |
250,000
+62,500
| +33% | +$2.81M |
|
502
Federal Realty Investment Trust
FRT
$10.7B
| $10.4M | 0.03% |
88,000
-4,500
| -5% | -$565K |
|
|
NLSN
503
DELISTED
Nielsen Holdings plc
NLSN
| $10.3M | 0.03% |
441,379
-21,500
| -5% | -$557K |
|
|
DISCK
504
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $10.3M | 0.03% |
445,390
-21,900
| -5% | -$610K |
|
505
uniQure
QURE
$3.03B
| $10.2M | 0.03% |
355,148
+21,200
| +6% | +$590K |
|
506
HF Sinclair
DINO
$16.3B
| $10.2M | 0.03% |
198,600
+190,300
| +2,293% | +$11.7M |
|
507
Cathay General Bancorp
CATY
$4.22B
| $10.1M | 0.03% |
302,000
+62,000
| +26% | +$2.35M |
|
508
Tapestry
TPR
$30.8B
| $10.1M | 0.03% |
299,042
-45,600
| -13% | -$1.84M |
|
509
JB Hunt Transport Services
JBHT
$25.5B
| $10.1M | 0.03% |
108,200
-5,300
| -5% | -$562K |
|
510
Newell Brands
NWL
$2.38B
| $10M | 0.03% |
537,900
-26,100
| -5% | -$519K |
|
|
CLLS
511
Cellectis
CLLS
$277M
| $9.99M | 0.03% |
600,000
-200,000
| -25% | -$4.64M |
|
512
Snap-on
SNA
$21.2B
| $9.92M | 0.03% |
68,273
-123,817
| -64% | -$19.6M |
|
|
IPG
513
DELISTED
Interpublic Group of Companies
IPG
| $9.8M | 0.03% |
+474,982
| New | +$10.9M |
|
514
Western Digital
WDC
$188B
| $9.58M | 0.03% |
342,838
-150,955
| -31% | -$5.35M |
|
|
AIMT
515
DELISTED
Aimmune Therapeutics
AIMT
| $9.57M | 0.03% |
+400,000
| New | +$10.4M |
|
516
Labcorp
LH
$25B
| $9.55M | 0.03% |
87,998
+21,999
| +33% | +$2.95M |
|
|
LOGC
517
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $9.46M | 0.03% |
+910,000
| New | +$11M |
|
|
ADVM
518
DELISTED
Adverum Biotechnologies
ADVM
| $9.45M | 0.03% |
300,000
| – | – |
|
519
Brown-Forman Class B
BF.B
$13.2B
| $9.43M | 0.03% |
198,132
-10,100
| -5% | -$480K |
|
520
Palo Alto Networks
PANW
$270B
| $9.42M | 0.03% |
300,000
+90,000
| +43% | +$2.81M |
|
521
LKQ Corp
LKQ
$5.68B
| $9.36M | 0.03% |
394,300
-19,300
| -5% | -$525K |
|
522
Packaging Corp of America
PKG
$21.9B
| $9.36M | 0.03% |
112,100
-5,700
| -5% | -$530K |
|
523
Avis
CAR
$4.86B
| $9.3M | 0.03% |
413,745
+313,745
| +314% | +$9.1M |
|
|
PTLA
524
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $9.27M | 0.03% |
+475,000
| New | +$9.77M |
|
525
LyondellBasell Industries
LYB
$20B
| $9.21M | 0.03% |
110,700
+73,600
| +198% | +$6.73M |
|
Similar funds
Adage Capital Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Adage Capital Partners held 799 positions worth $36.1B, down 19% from $44.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Adage Capital Partners withdrew a net $2.16B in Q4 2018, closing 95 positions and reducing 361 holdings. Its most notable exit was Aetna Inc, an estimated $946M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in CVS Health worth $106M.
- Adage Capital Partners's largest Q4 2018 buy was CVS Health: 1,619,774 shares worth $106M.
- Adage Capital Partners added most to GE Aerospace in Q4 2018, an estimated $347M increase.
- Adage Capital Partners's biggest Q4 2018 reduction was Shire pic, cutting an estimated $472M.
- Adage Capital Partners fully exited Aetna Inc in Q4 2018, selling an estimated $946M.
- Adage Capital Partners's ten largest holdings make up 16% of its $36.1B portfolio in Q4 2018.
- Adage Capital Partners opened 91 new positions and closed 95 in Q4 2018.
- Adage Capital Partners's portfolio value fell 19% quarter-over-quarter to $36.1B.
Based on Adage Capital Partners's 13F filing for Q4 2018, filed 14 Feb 2019.